Top compounds associated with response to C6orf229


Feature Type Standardized
Nominal ANOVA
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.098 0.004
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.099 0.005
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.005
mRNA PD318088 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.006
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.006
mRNA CI-976 CTRPv2 pan-cancer AAC 0.11 0.007
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.1 0.008
Download CSV